Ken Griffin’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-862,406
| Closed | -$28.6M | – | 6309 |
|
|
2025
Q1 | $28.6M | Sell |
862,406
-505,826
| -37% | -$16.8M | 0.01% | 711 |
|
|
2024
Q4 | $47.1M | Buy |
1,368,232
+1,213,556
| +785% | +$41.8M | 0.01% | 565 |
|
|
2024
Q3 | $6.19M | Sell |
154,676
-529,642
| -77% | -$21.2M | ﹤0.01% | 1597 |
|
|
2024
Q2 | $20.6M | Buy |
684,318
+102,698
| +18% | +$3.1M | ﹤0.01% | 859 |
|
|
2024
Q1 | $19.5M | Buy |
581,620
+502,887
| +639% | +$16.9M | ﹤0.01% | 902 |
|
|
2023
Q4 | $2.54M | Sell |
78,733
-163,347
| -67% | -$5.28M | ﹤0.01% | 2210 |
|
|
2023
Q3 | $7.93M | Sell |
242,080
-558,780
| -70% | -$18.3M | ﹤0.01% | 1298 |
|
|
2023
Q2 | $28.2M | Buy |
800,860
+269,053
| +51% | +$9.47M | 0.01% | 657 |
|
|
2023
Q1 | $17.4M | Buy |
531,807
+395,854
| +291% | +$12.9M | ﹤0.01% | 927 |
|
|
2022
Q4 | $7.49M | Sell |
135,953
-8,250
| -6% | -$455K | ﹤0.01% | 1494 |
|
|
2022
Q3 | $6.39M | Buy |
144,203
+70,740
| +96% | +$3.13M | ﹤0.01% | 1641 |
|
|
2022
Q2 | $3.58M | Sell |
73,463
-95,016
| -56% | -$4.63M | ﹤0.01% | 2193 |
|
|
2022
Q1 | $8.2M | Buy |
168,479
+78,048
| +86% | +$3.8M | ﹤0.01% | 1591 |
|
|
2021
Q4 | $3.86M | Buy |
90,431
+49,384
| +120% | +$2.11M | ﹤0.01% | 2361 |
|
|
2021
Q3 | $1.57M | Sell |
41,047
-3,724
| -8% | -$143K | ﹤0.01% | 3274 |
|
|
2021
Q2 | $1.26M | Sell |
44,771
-6,008
| -12% | -$170K | ﹤0.01% | 3721 |
|
|
2021
Q1 | $1.68M | Buy |
50,779
+23,196
| +84% | +$767K | ﹤0.01% | 3362 |
|
|
2020
Q4 | $997K | Sell |
27,583
-192,010
| -87% | -$6.94M | ﹤0.01% | 3252 |
|
|
2020
Q3 | $7.45M | Buy |
+219,593
| New | +$7.45M | ﹤0.01% | 1269 |
|